日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer

一项评估黄酮吡啶醇(Alvocidib)联合多西他赛治疗难治性转移性胰腺癌的II期研究

Carvajal, Richard D; Tse, Archie; Shah, Manish A; Lefkowitz, Robert A; Gonen, Mithat; Gilman-Rosen, Lisa; Kortmansky, Jeremy; Kelsen, David P; Schwartz, Gary K; O'Reilly, Eileen M